Section Review Biologicals & Immunologicals: Matrix metalloproteinases and malignant disease: Recent developments
- 3 March 1996
- journal article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 5 (3) , 323-335
- https://doi.org/10.1517/13543784.5.3.323
Abstract
One important proteolytic event during metastasis and angiogenesis appears to be the degradation of basement membrane components. A specific class of extracellular matrix (ECM) degrading metallo-enzymes, the matrix metalloproteinases (MMPs), also known as the matrixins, are thought to have a critical role in the creation of the proteolytic defect in basement membrane type IV collagen that allows tumour cells to escape from their primary site. The expression of matrixin proteases has been linked with many physiologic and pathologic processes involving ECM turnover. A number of correlative and functional studies suggest that the action of MMPs is required during tumour invasion and progression, as well as angiogenesis. The correlative studies have demonstrated overexpression of MMPs in many human cancer tissues at both the protein (immunoperoxidase) and mRNA (in situ hybridisation) levels. Functional studies have used endogenous inhibitors (Tissue Inhibitors of Metalloproteinases, TIMPs) or synthetic MMP in...Keywords
This publication has 88 references indexed in Scilit:
- Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic MiceJNCI Journal of the National Cancer Institute, 1995
- Inhibition of Human Stromelysin by Peptides Based on the N-Terminal Domain of Tissue Inhibitor of Metalloproteinases-1Biochemical and Biophysical Research Communications, 1994
- Angiogenic potential in vivo by Kaposiʼs sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2AIDS, 1994
- Inhibition of collagenolytic activity relates to quantitative reduction of invasionin vitro in a c-Ha-ras transfected glial cell lineJournal of Neuro-Oncology, 1994
- Type IV collagenases in invasive tumorsBreast Cancer Research and Treatment, 1993
- Differential regulation of TIMP-1 and TIMP-2 mRNA expression in normal and Ha-ras-transformed murine fibroblastsGene, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2)Biochemical and Biophysical Research Communications, 1990
- Gelatinases of murine metastatic tumor cellsBiochemical and Biophysical Research Communications, 1989
- Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotypeBiochemical and Biophysical Research Communications, 1988